WHENNovember 06, 2010 @ 8:00am - 5:00pm
Date: Nov 06, 2010
Type: Association Events
Organizer: SABPA
Location: Institute of Americas, UCSD
Source: SABPA

[nggallery id=26] Written Report: Click Here
When: 8:30 am 4:20 pm, Saturday, November 6, 2010
Where: Institute of Americas, UCSD
$20 for early birds (by Oct. 31), $30 before the end of Nov. 3, $50 for onsite registration, students and postdocs $10 off (The fees include program brochure, continental breakfast, coffee break, lunch and onsite reception).Online registration closes on Nov. 3.8:30 am Breakfast and Registration
9:00 am Opening Remarks
Peter Zhu, Executive VP, SABPA, Senior Scientist, Pfizer
Zhu Shen, Ph.D., MBA, Co-Chair of Pacific Forum & Vice Chairman, SABPA; CEO, BioForesight
9:10 am Asia Pacific – How to Spot the Real Opportunities
Gunther Winkler, Ph.D., Senior VP, Asia Pacific and Global Government Strategy, Biogen Idec
Introduction: Ping Yeh, Ph.D., Director, Protein Pharmaceutical Development Technical Development, Biogen Idec
9:40 am Panel Discussion:Bio-Pharma R&D collaboration around Pacific Rim
Session Leader:William Looney, Editor-in-Chief from PharmExecutive
Introduction: Zhu Shen
Xiaochuan Wang,Ph.D., CEO, Sundia MediTech Company, Ltd.
James Schaeffer, Ph.D., Executive Director, Licensing & External Research, Merck
Michael J. Reilly, MBA, Co-founder & CEO, Western States Biopharmaceuticals, Inc.
Yong Qian,Ph.D., CEO, BioMedicure
Raymond Price, PhD, MBA, Director of Business Development, GenScript
10:40 amCoffee Break
11:00 amExternal Research in Asia: A dazzling Future
Richard Connell, Ph.D., VP and Worldwide Head of Pfizer External Research SolutionsSlides
Introduction: Stephanie Shi, Senior Principal Scientist, Pfizer
11:40 amUnderstanding and Overcoming the Challenges Surrounding International Logistics of Biopharmaceutical Materials
Kevin Xu,General Manager, Biocair China
Introduction: Mingzhu Zhang, Ph.D., Chair of Fund Raising, SABPA; VP, Business development, Shanghai Medicilon
12:00 pm Lunch
1:00 pmThe Evolving Model for CRO’s: Value-creation by Providing Innovative Integrated Drug Discovery Services and Know-how.
Lee Babiss, Ph.D., Executive VP, Global Lab Services, PPDSlides
Introduction: Hui Li, Ph.D., Vice Chairman, SABPA, Director, PPD
1:30 pm IP Strategies for Acquiring Multinationals Business in China
Jie Zhou, Ph.D., Partner, Morrison Foerster
Introduction: Zheng Liu, Co-Chair of Pacific Forum, SABPA
2:00 pmPanel Discussion:Trans-Pacific Partnering & Licensing Opportunities & IP issues
Session Leader:Jerry Hefner, Ph.D., Partner, Knobbe Martens Olson & Bear LLP
Introduction: Yang Liu, Ph.D., Co-Chair of Fund Raising, SABPA; Director of R&D, Stemgent, Inc.
Dong Liu, Ph.D., Senior Partner, Boss & Young
Keiko Mitsunobu, President, UpWell
Jie Liu D’Elia, Ph.D., VP of International Business Development, Simcere Pharmaceutical
Li Chen, Ph.D., CEO, Hua Medicine
3:00 pm Coffee Break
3:20 pm Medical reform in China and its impact on pharmaceutical companies
Hengpeng Zhu, Ph.D., Professor, Chinese Academy of Social Sciences(CASS);Director, Micro-economic Research Office, Institute of Economics, CASSSlides
Introduction: Zhi Wang, Senior Manager, Goverment Relations, Strategic Initiatives and Asia Pacific, Biogen Idec
3:40 pm A Chinese Local Pharmaceutical Companys Innovation Strategy–Luye Pharma
Gang Cheng, Ph.D., International Tech Transfer & Collaboration Manager, Luye PharmaSlides
Shandong International Biotechnology Park (BIOasis) Introduction
Shumin Zhang, Executive VP, BIOasisSlides
Introduction: Yahua Liu, Ph.D., Chair of Social Events, SABPA; Investigator, GNF
4:10 pmClosing Remark
Ming Guo, Ph.D., Co-founder and board director, SABPA; Co-founder and COO, Ascentage Pharma
4:20 pmOnsite Reception